Scientists will start the
first large-scale tests of Ebola vaccine, one developed in the USA and one
developed in Canada, on people in West Africa within a few weeks, announced
U.S. authorities on Thursday.
Anthony Fauci, director
of the National Institute of Allergy and Infectious Disease said that
scientists at the National Institutes of Health (NIH) would partner with the
Liberian government to launch a clinical trial of two vaccines.
The Sierra Leone
government will work with researchers at the Centers for Disease Control and
Prevention to test one of the vaccines.
Scientists at the Centers
for Disease Control and Prevention will work with the government of Sierra Leone
to test one of the vaccines.
An effective Ebola
vaccine could help to control the current outbreak and could be lifesaving in
Beyond vaccines, NIH
doctors will work with Liberia to test the experimental treatment drug Zmapp.
The drug has been given to several Ebola patients but has never been formally
tested in humans, officials say. The studies will be conducted in the USA and
According to the World
Health Organization, Ebola has infected 21,759 people and killed 8,668, primarily
in Guinea, Liberia and Sierra Leone.